𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease

✍ Scribed by Bart Post; Dino Muslimovic; Nan van Geloven; Johannes D. Speelman; Ben Schmand; Rob J. de Haan; on behalf of the CARPA-study group


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
128 KB
Volume
26
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Objective:

To determine progression and prognostic factors of progression rate of motor impairment, disability, and quality of life (QoL) in patients with newly diagnosed Parkinson's disease.

Methods:

A group of 126 patients with newly diagnosed PD recruited from outpatient clinics participated in this 3‐year prospective cohort study. Motor impairment was rated with the Unified Parkinson Disease Rating Scale Motor‐Examination. Disability was rated using the Schwab and England Activities of Daily Living Scale, the AMC Linear Disability Score. QoL was assessed with the Parkinson's Disease Quality of Life questionnaire. Linear mixed model analyses were conducted to identify determinants of progression rate of motor impairment, disability, and poor QoL.

Results:

Motor impairment progressed with 3 points per year. There was a slight progression of disability and QoL during 3 years of follow‐up. Female sex was a prognostic factor for slower progression of motor impairment and QoL. Older age at onset showed to prognosticate faster progression of disability and impaired QoL. Furthermore, independent of follow‐up time, older age at onset was associated with worse motor impairment; nondopaminergic reactive symptoms (Axial impairment) were associated with more disability and poorer QoL; comorbidity showed relation with disability and QoL but to a lesser extent; self‐reported mood symptoms were associated with poorer QoL; and disease duration correlated with motor impairment.

Conclusions:

Motor impairment, disability, and QoL of newly diagnosed Parkinson patients show progression in the first 3 years. Older age at onset predicts worse progression rate of disability and impaired QoL over time. Female sex predicts slower progression of motor impairment and less decline of QoL. Β© 2011 Movement Disorder Society


πŸ“œ SIMILAR VOLUMES


Distribution of motor impairment influen
✍ Kim C. Stewart; Hubert H. Fernandez; Michael S. Okun; Charles E. Jacobson; Chris πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 418 KB πŸ‘ 1 views

## Abstract We evaluated the relationship between upper extremity (UE) and lower extremity (LE) motor impairments in Parkinson's disease (PD) to overall disability and quality of life (QoL) measures. A total of 639 patients who were diagnosed with idiopathic PD were administered the Unified Parkins

Differential progression of motor impair
✍ Christopher G. Goetz; Glenn T. Stebbins; Lucy M. Blasucci πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 68 KB πŸ‘ 2 views

OBJECTIVE: To monitor comparative progression of clinical impairment over 4 years in patients with Parkinson's disease (PD) who present on levodopa at two different levels of Hoehn and Yahr (HY) stages, II and III. BACKGROUND: The rate of clinical impairment progression in patients with PD being tr

Quality of life in early Parkinson's dis
✍ Connie Marras; Anthony Lang; Murray Krahn; George Tomlinson; Gary Naglie πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 1 views

## Abstract The impact of dyskinesias and motor fluctuations on quality of life (QOL) at various stages in the course of Parkinson's disease (PD) is not well understood. In 301 subjects with early PD enrolled in a clinical trial (CALM‐PD), we quantified the impact of motor complications on QOL and

Rating impairment and disability in Park
✍ Dr. J. J. van Hilten; A. D. van der Zwan; A. H. Zwinderman; R. A. C. Roos πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 411 KB πŸ‘ 1 views

## Abstract Although the Unified Parkinson's Disease Rating Scale (UPDRS) is widely used to monitor disease progression and drug efficacy, no attempts have been made to evaluate its scientific and clinical quality. Poor clinical sensibility of items in the activities of daily living (ADL) section a

Systematic evaluation of rating scales f
✍ Claudia Ramaker; Johan Marinus; Anne Margarethe Stiggelbout; Bob Johannes van Hi πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 101 KB πŸ‘ 1 views

## Abstract We assessed the clinometric characteristics of rating scales used for the evaluation of motor impairment and disability of patients with Parkinson's disease (PD), conducting a systematic review of PD rating scales published from 1960 to the present. Thirty studies describing clinometric

Risk factors for Parkinson's disease and
✍ Andrew Siderowf; Danna Jennings; James Connolly; Richard L. Doty; Kenneth Marek; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 1 views

## Abstract Our objective was to assess the association between risk factors for Parkinson's disease (PD) and abnormal olfaction in first‐degree relatives of patients with PD. Factors including lower cigarette smoking and lower caffeine consumption have been associated with increased risk of PD. Id